AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer,...
Read moreFollowing NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care....
Read moreCould the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the...
Read morePfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment...
Read moreThe use of excessively fragile efficacy data and delays in sponsors' presenting living proof from post-approval trials, as well as...
Read moreThe oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival...
Read moreOn the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the...
Read moreAccording to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers...
Read moreThe FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to...
Read moreAs infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.